NCT05524883: An ongoing trial by Dyne Therapeutics
This trial is ongoing. It must report results 6 years from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05524883 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study Assessing Safety, Tolerability, Pharmacodynamics, Efficacy, and Pharmacokinetics of DYNE-251 Administered to Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 12, 2022 |
| Completion date | Sept. 30, 2031 |
| Required reporting date | Sept. 29, 2032, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Sept. 16, 2026 |
| Days late | None |